MedTrace Logo

MAPT Haploid H1b and the Damage of BBB in Dorsal Medulla Oblongata and Autonomic Dysfunction in PD

NCT05471713 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-07-25

No results posted yet for this study

Summary

This study mainly explored the relationship between the permeability of the blood-brain barrier in the dorsal medulla oblongata and autonomic dysfunction, and the relationship and mechanism of MAPT genotype on the permeability of the blood-brain barrier and the progression of autonomic dysfunction in PD patients.

Conditions

Interventions

OTHER

Autonomic dysfunction

Autonomic dysfunction

Sponsors & Collaborators

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • shuzhen zhu, doctor · Southern Medical University, China

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05471713 on ClinicalTrials.gov